P

Pacira BioSciences
D

PCRX

25.170
USD
-0.59
(-2.29%)
مغلق
حجم التداول
16,341
الربح لكل سهم
4
العائد الربحي
-
P/E
-13
حجم السوق
1,162,180,451
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.350
    (-1.73%)
    19.940 USD
    A
    AMRN
    -0.00130
    (-0.22%)
    0.58930 USD
    B
    BHC
    0.13500
    (1.88%)
    7.31000 USD
    R
    RDNT
    -3.289
    (-5.24%)
    59.430 USD
    TEVA
    TEVA
    -0.255
    (-1.50%)
    16.745 USD
    المزيد
الأخبار
المقالات

العنوان: Pacira BioSciences

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.